الرئيسية › السرطان (جميع الأنواع) › تينيسي › Nashville
التجارب السريرية لـ السرطان (جميع الأنواع) في Nashville، TN
65 دراسات لـ السرطان (جميع الأنواع) تبحث عن مشاركين في مواقع داخل وحول Nashville (ضمن نطاق 30 ميلًا تقريبًا). افتح الدراسة لمعرفة من يمكنه المشاركة وكيفية التواصل مع فريق الدراسة.
النص الرسمي للدراسة (بالإنجليزية)
تبحث عن مشاركين لدراسة؟ أبرزها في أعلى الصفحة — $99 لمدة 30 يومًا →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
جارٍ التسجيلالمرحلة 2/3
- SCRI Oncology Partners /ID# 276959, Nashville
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
جارٍ التسجيلالمرحلة 2
- SCRI Oncology Partners /ID# 279733, Nashville
A Study of ASP3082 in Adults With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- Vanderbilt University Medical Center, Nashville
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
جارٍ التسجيلالمرحلة 3
- SCRI Oncology Partners, Nashville
A Study of PHN-012 in Patients With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- PHN-012-001 Site, Nashville
Registry Study for Radiation Therapy Outcomes
جارٍ التسجيلدراسة رصدية
- Tennessee Oncology Proton Center, Franklin · على بُعد 17 ميل
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
جارٍ التسجيلدراسة رصدية
- Vanderbilt University Medical Center, Nashville
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- GSK Investigational Site, Nashville
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
جارٍ التسجيلدراسة رصدية
- Vanderbilt University Medical Center, Nashville
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
جارٍ التسجيلالمرحلة 2/3
- Henry-Joyce Cancer Clinic, Nashville
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
جارٍ التسجيلالمرحلة 1
- Sarah Cannon Cancer Institute, Nashville
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
جارٍ التسجيلالمرحلة 3
- Sarah Cannon Research Institute, Nashville
- United States Oncology Regulatory Affairs Corporate Office, Nashville
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
جارٍ التسجيلالمرحلة 1
- SCRI Oncology Partners, Nashville
A Study of JNJ-87890387 for Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- Sarah Cannon Research Institute, Nashville
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
جارٍ التسجيلالمرحلة 3
- Vanderbilt University Medical Center, Nashville
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
جارٍ التسجيلالمرحلة 3
- Quetzal Site 12, Nashville
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
جارٍ التسجيلالمرحلة 3
- SCRI Oncology Partners /ID# 279779, Nashville
- Vanderbilt University Medical Center /ID# 280169, Nashville
Pan Tumor Rollover Study
جارٍ التسجيلالمرحلة 2
- Tennesse Oncology, Nashville
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
جارٍ التسجيلالمرحلة 3
- SCRI Oncology Partners ( Site 7000), Nashville
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
جارٍ التسجيلالمرحلة 2
- Tennessee Oncology - Nashville / Sarah Cannon Research Institute, Nashville
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Sarah Cannon Research Institue, Nashville
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
جارٍ التسجيلالمرحلة 2/3
- Sarah Cannon Research Inst, Nashville
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- GSK Investigational Site, Nashville
A Phase 1/1b Study of IAM1363 in HER2 Cancers
جارٍ التسجيلالمرحلة 1
- SCRI Oncology Partners, Nashville
- Vanderbilt Ingram Cancer Center, Nashville
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- Sarah Cannon Research Center, Nashville
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
جارٍ التسجيلالمرحلة 1/2
- SCRI Oncology Partners, Nashville
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
جارٍ التسجيلالمرحلة 3
- Research Site, Nashville
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
جارٍ التسجيلالمرحلة 3
- Tennessee Oncology, Nashville
- USO - US Oncology Research Network, Nashville
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
جارٍ التسجيلدراسة رصدية
- Vanderbilt University, Nashville
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
جارٍ التسجيلالمرحلة 3
- Tennessee Oncology PLLC - Chattanooga, Nashville
- Tennessee Oncology, PLLC, Nashville
- Vanderbilt University Medical Center, Nashville
Project: Every Child for Younger Patients With Cancer
جارٍ التسجيلدراسة رصدية
- The Children's Hospital at TriStar Centennial, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
FOG-001 in Locally Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Sarah Cannon Research Institute, Nashville
- Vanderbilt Ingram Cancer Center, Nashville
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
جارٍ التسجيلالمرحلة 3
- Vanderbilt Breast Center at One Hundred Oaks, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
- Vanderbilt-Ingram Cancer Center at Franklin, Franklin · على بُعد 17 ميل
- و 1 أخرى
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- SCRI Oncology Partners, Nashville
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Sara Cannon Research Institute Tennessee, Nashville
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
جارٍ التسجيلالمرحلة 1
- Vanderbilt Ingram Cancer Center /ID# 252470, Nashville
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
جارٍ التسجيلالمرحلة 2
- SCRI Oncology Partners /ID# 274522, Nashville
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Sarah Cannon Research Institute, Nashville
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
جارٍ التسجيلالمرحلة 2
- Vanderbilt University, Ingram Cancer Center, Nashville
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
جارٍ التسجيلالمرحلة 1/2
- Tennessee Oncology, Nashville
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
جارٍ التسجيلالمرحلة الأولى المبكرة
- Vanderbilt University Medical Center, Nashville
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
جارٍ التسجيلالمرحلة 1
- GSK Investigational Site, Nashville
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
جارٍ التسجيلالمرحلة 1
- Sarah Cannon, SCRI Oncology Partners, Nashville
CT-95 in Advanced Cancers Associated With Mesothelin Expression
جارٍ التسجيلالمرحلة 1
- Context Investigational Site, Nashville
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
جارٍ التسجيلالمرحلة 1/2
- Vanderbilt University Medical Center, Nashville
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
جارٍ التسجيلالمرحلة 1
- Research Site, Nashville
Galleri® in the Medicare Population.
جارٍ التسجيلمرحباً بالمتطوعين الأصحاء
- HCA Healthcare Centennial, Nashville
- HCA Healthcare Nashville, Nashville
- HCA Healthcare Brentwood, Brentwood · على بُعد 9 ميل
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
جارٍ التسجيلالمرحلة 1
- GSK Investigational Site, Nashville
Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma
جارٍ التسجيلالمرحلة 1
- Vanderbilt University Medical Center, Nashville
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- Sarah Cannon Research Institute, Nashville
Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy
جارٍ التسجيلالمرحلة الأولى المبكرة
- Vanderbilt University Medical Center, Nashville
High-Resolution PET-CT Imaging for Surgical Margin Visualization
جارٍ التسجيل
- Vanderbilt University Medical Center, Nashville
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
جارٍ التسجيلالمرحلة 1
- SCRI Oncology Partners, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1
- SCRI Oncology Partners, Nashville
Suprachoroidal Administration in Subjects With Metastases to the Choroid
جارٍ التسجيلالمرحلة 2
- Tennessee Retina, PC, Nashville
A Study of YL242 in Subjects With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- US-205, Nashville
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1
- Vanderbilt-Ingram Cancer Center, Nashville
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
جارٍ التسجيلالمرحلة 1
- Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
جارٍ التسجيلدراسة رصدية
- Massive Bio SYNERGY-AI site, Nashville
Inherited CAncer REgistry
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- Vanderbilt-Ingram Cancer Center, Nashville
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Sarah Cannon Research Institute, Nashville
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
جارٍ التسجيلالمرحلة 1/2
- SCRI Oncology Partners, Nashville
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
جارٍ التسجيلالمرحلة 1/2
- Verdi Oncology Tennessee, Scri Oncology Partners, Nashville
Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up
جارٍ التسجيلدراسة رصدية
- Provision CARES Proton Therapy Nashville, Franklin · على بُعد 17 ميل
تجارب السرطان (جميع الأنواع) في مدن أخرى
- Houston, TX121 دراسات
- New York City, NY109 دراسات
- Boston, MA85 دراسات
- Los Angeles, CA74 دراسات
- Philadelphia, PA59 دراسات
- Washington, DC58 دراسات
- Durham, NC58 دراسات
- Chicago, IL51 دراسات
- Atlanta, GA49 دراسات
- Seattle, WA49 دراسات
- Arlington, VA48 دراسات
- St. Louis, MO46 دراسات
دراسات أخرى في Nashville
- سرطان الرئة غير صغير الخلايا97 دراسات
- سرطان الثدي81 دراسات
- السرطان النقيلي70 دراسات
- سرطان القولون والمستقيم69 دراسات
- سرطان المبيض49 دراسات
- سرطان البروستاتا43 دراسات
- سرطان الرئة40 دراسات
- سرطان الخلايا الحرشفية في الرأس والرقبة39 دراسات
- سرطان البنكرياس39 دراسات
- سرطان بطانة الرحم38 دراسات
- ميلانوما33 دراسات
- الورم النقوي المتعدد32 دراسات
من ClinicalTrials.gov، البيانات مستخرجة في 06/10/2026. كل دراسة تحدد معايير أهليتها الخاصة؛ فريق الدراسة هو من يحدد من يمكنه المشاركة.